1 From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.). ssfranklinmd@earthlink.net.
2 From the Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine (S.S.F.); Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland (E.O'B.); Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium (L.T., K.A., J.A.S.); Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences, Sendai, Japan (K.A.); Maastricht University, Maastricht, The Netherlands (J.A.S.); and Vitak Research and Development, Maastricht University, Maastricht, The Netherlands (J.A.S.).